Earnings
ABMD
333.11
-0.21%
-0.70
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-03-31
192.34M
250.78M
--
84.65M
--
--
0.00
--
90.09M
--
18.01M
--
635.86M
176.69M
--
302.24M
--
31.97M
22.58M
--
47.12M
580.60M
1.22B
--
32.77M
0.00
--
--
--
--
--
57.14M
--
--
--
41.97M
131.88M
0.00
--
--
806.00K
18.30M
19.11M
151.00M
451.00K
739.13M
602.48M
-265.41M
--
--
1.07B
1.07B
1.22B
FY 2019-03-31
121.02M
370.68M
--
90.81M
--
--
0.00
--
80.94M
--
13.75M
--
677.20M
145.00M
--
102.52M
--
32.60M
15.21M
--
81.82M
377.15M
1.05B
--
32.19M
0.00
--
--
--
--
--
45.16M
--
--
--
28.66M
106.00M
0.00
--
--
822.00K
10.64M
11.46M
117.46M
451.00K
690.51M
399.47M
-138.85M
--
--
936.89M
936.89M
1.05B
FY 2018-03-31
42.98M
319.27M
--
70.01M
--
--
0.00
--
50.20M
--
11.81M
--
494.27M
117.17M
--
50.10M
--
35.81M
16.70M
--
72.32M
292.10M
786.38M
--
23.57M
0.00
--
--
--
--
--
41.59M
--
--
--
19.53M
84.68M
0.00
--
--
903.00K
11.27M
12.17M
96.85M
444.00K
619.90M
140.46M
-67.08M
--
--
689.52M
689.52M
786.38M
FY 2017-03-31
39.04M
190.91M
--
54.05M
--
--
0.00
--
34.93M
--
8.02M
--
326.96M
87.78M
--
47.14M
--
31.05M
14.48M
--
43.01M
223.46M
550.41M
--
20.62M
0.00
--
--
--
--
--
34.52M
--
--
--
13.68M
69.62M
15.54M
--
--
783.00K
12.40M
28.73M
98.34M
437.00K
565.96M
-46.96M
-46.76M
--
--
452.07M
452.07M
550.41M
FY 2016-03-31
48.23M
163.82M
--
42.82M
--
--
0.00
--
26.74M
--
6.78M
--
288.39M
23.18M
--
1.00M
--
33.00M
15.40M
--
62.96M
135.54M
423.93M
--
9.38M
0.00
--
--
--
--
--
25.86M
--
--
--
11.30M
46.54M
0.00
--
--
832.00K
7.78M
8.62M
55.16M
426.00K
508.62M
-99.08M
-26.66M
--
--
368.77M
368.77M
423.93M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ABMD latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Abiomed recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.